XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Ordinary Shares
Capital in Excess of Par Value
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning Equity Balance at Dec. 31, 2023 $ 2 $ 693,841 $ (1,435) $ (554,231) $ 138,177
Beginning Equity Balance (shares) at Dec. 31, 2023 63,601,015,000        
Share based compensation activity   4,739     4,739
Share based compensation activity (shares) 441,348,000        
Issuance of ordinary shares in at-the-market offering   1,586     1,586
Issuance of ordinary shares in at-the-market offering (shares) 256,328,000        
Issuance costs in connection with ordinary shares   (635)     (635)
Other comprehensive loss     (1,691)   (1,691)
Net loss for the period       (20,442) (20,442)
Ending Equity Balance at Mar. 31, 2024 $ 2 699,531 (3,126) (574,673) 121,734
Ending Equity Balance (shares) at Mar. 31, 2024 64,298,691,000        
Beginning Equity Balance at Dec. 31, 2023 $ 2 693,841 (1,435) (554,231) 138,177
Beginning Equity Balance (shares) at Dec. 31, 2023 63,601,015,000        
Net loss for the period         (20,442)
Ending Equity Balance at Dec. 31, 2024 $ 3 773,565 (3,719) (702,022) 67,827
Ending Equity Balance (shares) at Dec. 31, 2024 78,397,380        
Share based compensation activity   2,130     2,130
Share based compensation activity (shares) 457,679        
Issuance of ordinary shares in at-the-market offering   4,482     4,482
Issuance of ordinary shares in at-the-market offering (shares) 563,379        
Issuance costs in connection with ordinary shares   (12)     (12)
Other comprehensive loss     (1,347)   (1,347)
Net loss for the period       (39,981) (39,981)
Ending Equity Balance at Mar. 31, 2025 $ 3 $ 780,165 $ (5,066) $ (742,003) $ 33,099
Ending Equity Balance (shares) at Mar. 31, 2025 79,418,438